Analyst Research
| Report Title | Price |
|---|---|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
BGS Energy Plus as's Subsidiary Concludes Agreement with FITEN SA for Acquisition of 100% Stake in Bioelektrownia Przykona Sp. z o.o.
BGS Energy Plus as announced that on April 17, 2013 its 82%-owned subsidiary, VOLTA EUROPE BGS Spolka z o.o., concluded a conditional share transfer agreement with Fiten SA concerning the purchase of 20,577 shares, which constitute a 100% stake in the share capital of Bioelektrownia Przykona Sp. z o.o., with a face value of PLN 50 each, to a total face value of PLN 1,028,850 in the share capital of Bioelektrownia Przykona Sp. z o.o. in exchange for a total price of PLN 190,251.59.
Latest Developments for Mertiva AB
- Mertiva AB to Delist from Nasdaq OMX and List on Nordic MTF
- Diamyd Medical AB Plans to Delist from NasdaqOMX and to List on Another Marketplace
- Diamyd Medical AB Appoints Andreas Bergsten as New CEO
- Diamyd Medical AB Changes Name to Mertiva AB, Distributes Shares in Subsidiary to Shareholders and Appoints Hakan Blomdahl as Chairman
Latest Key Developments in Biotechnology
- Biogen Idec Inc And Swedish Orphan Biovitrum AB Presents New Data From Phase 3 Study Of Long-Lasting Hemophilia Factor Candidate ALPROLIX
- Novation Holdings Inc Announces Acquisition Of Controlling Interest In Solar Energy Initiatives Inc
- La Jolla Pharmaceutical Co Announces FDA Acceptance Of IND For LJPC-501
- Portola Pharmaceuticals Inc Announces Positive Phase 2 Study Results Showing Factor Xa Inhibitor Antidote PRT4445 Reverses Anticoagulant Activity Of Eliquis
- Share this
- Link this
- Digg this
Follow Reuters